Key Insights

Highlights

Treatment Research

2 treatments under study, led by Intraportal Islet Autotransplantation

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1/2 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Research Network

Common Treatments

  • Intraportal Islet Autotransplantation1
  • Total Pancreatectomy1

Active Sponsors

  • University Hospital, Lille1
  • Ministry of Health, France1

Top Investigators

Related Conditions

  • Adenocarcinoma Of The Pancreas1
  • Ampullary Adenocarcinoma1

Activity Timeline